Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Hodgkin Disease × etoposide phosphate × Clear all

Phase

Status

Completed 11 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Neoplasms, Germ Cell and Embryonal 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Acute 2 Teratoma 1 Seminoma 1 Sarcoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pinealoma 1 Osteosarcoma 1 Nonseminomatous germ cell tumor 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Medulloblastoma 1 Lymphoma, T-Cell 1 Lymphoma, Primary Effusion 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, AIDS-Related 1 Lymphoma 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Histiocytosis, Langerhans-Cell 1 Germinoma 1

Interventions

Doxorubicin 10 Cyclophosphamide 10 Vinblastine 9 Nivolumab 9 Dacarbazine 8 Brentuximab Vedotin 8 fludarabine phosphate 6 fludarabine 6 Radiotherapy 6 Etoposide 6 Bleomycin 6 pembrolizumab 5 Melphalan 5 Whole-Body Irradiation 4 Vincristine 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Tacrolimus 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Busulfan 3 Thiotepa 2 Sirolimus 2 Radiation 2 Procarbazine 2 Prednisolone 2 Mechlorethamine 2 Carmustine 2 Bendamustine Hydrochloride 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03407144 2026-02-19

MK-3475-667

Merck Sharp & Dohme LLC

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡